HK1259290A1 - 用聚乙烯哌嗪衍生物製備透明質酸酶綴合物的方法以及所得綴合物的應用 - Google Patents

用聚乙烯哌嗪衍生物製備透明質酸酶綴合物的方法以及所得綴合物的應用

Info

Publication number
HK1259290A1
HK1259290A1 HK19101651.7A HK19101651A HK1259290A1 HK 1259290 A1 HK1259290 A1 HK 1259290A1 HK 19101651 A HK19101651 A HK 19101651A HK 1259290 A1 HK1259290 A1 HK 1259290A1
Authority
HK
Hong Kong
Prior art keywords
conjugate
polyethylenepiperazine
derivatives
produced
producing hyaluronidase
Prior art date
Application number
HK19101651.7A
Other languages
English (en)
Inventor
阿卡迪亞‧瓦西里維奇‧尼克拉索夫
圖穆利‧馬薩維奇‧卡拉普塔茲
謝爾蓋‧阿列克謝維奇‧梅德韋杰夫
亞力山大‧弗拉基米羅維奇‧科祖科夫
尼諾‧圖穆里耶納‧卡拉普塔茲
Original Assignee
Npo佩特洛瓦克斯制藥有限責任公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Npo佩特洛瓦克斯制藥有限責任公司 filed Critical Npo佩特洛瓦克斯制藥有限責任公司
Publication of HK1259290A1 publication Critical patent/HK1259290A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F26/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen
    • C08F26/06—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen by a heterocyclic ring containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/02—Alkylation
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/06—Oxidation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Cosmetics (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK19101651.7A 2015-12-04 2019-01-30 用聚乙烯哌嗪衍生物製備透明質酸酶綴合物的方法以及所得綴合物的應用 HK1259290A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2015152036A RU2616528C1 (ru) 2015-12-04 2015-12-04 Способ получения конъюгата гиалуронидазы с производными полиэтиленпиперазина и применение полученного конъюгата
PCT/RU2016/000755 WO2017095264A1 (ru) 2015-12-04 2016-11-09 Способ получения конъюгата гиалуронидазы с производными полиэтиленпиперазина и применение полученного конъюгата

Publications (1)

Publication Number Publication Date
HK1259290A1 true HK1259290A1 (zh) 2019-11-29

Family

ID=58642685

Family Applications (1)

Application Number Title Priority Date Filing Date
HK19101651.7A HK1259290A1 (zh) 2015-12-04 2019-01-30 用聚乙烯哌嗪衍生物製備透明質酸酶綴合物的方法以及所得綴合物的應用

Country Status (19)

Country Link
US (1) US11364283B2 (zh)
EP (1) EP3384917B1 (zh)
JP (1) JP6683827B2 (zh)
KR (2) KR20200131355A (zh)
CN (1) CN108697732B (zh)
AR (1) AR108562A1 (zh)
CA (1) CA3007389C (zh)
EA (1) EA030139B1 (zh)
GE (1) GEP20207131B (zh)
HK (1) HK1259290A1 (zh)
HU (1) HUE056845T2 (zh)
LT (1) LT3384917T (zh)
MD (1) MD4637C1 (zh)
RS (1) RS62659B1 (zh)
RU (1) RU2616528C1 (zh)
SI (1) SI3384917T1 (zh)
TR (1) TR201807851T1 (zh)
UA (1) UA121425C2 (zh)
WO (1) WO2017095264A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7463110B2 (ja) * 2017-06-29 2024-04-08 ユニヴァーシティ オブ ワシントン Ｎ－オキシド及びエクトインモノマー、ポリマー、それらの組成物及び関連方法
RU2737271C2 (ru) * 2018-06-27 2020-11-26 ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НПО Петровакс Фарм" Сополимеры ди-N-оксидов поли-1,4-этиленпиперазина и способы их получения
CN111978404A (zh) * 2020-08-11 2020-11-24 西北大学 基于Halo-tag特异性脱卤反应的蛋白质一步定向固定化方法
KR102481458B1 (ko) 2021-12-15 2022-12-27 홍재혁 문신기구

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2801723B2 (ja) 1990-01-26 1998-09-21 花王株式会社 新規ベタイン及びそれを含有する分散剤
RU2073031C1 (ru) * 1990-08-06 1997-02-10 Некрасов Аркадий Васильевич Производные поли-1,4-этиленпиперазина, обладающие иммуномодулирующей, противовирусной и антибактериальной активностями
EP0789586B1 (en) * 1993-09-10 2001-07-04 Petrovax, Inc. Compounds for the prevention and treatment of helminth infections
RU2112542C1 (ru) * 1997-02-28 1998-06-10 Аркадий Васильевич Некрасов Препарат для лечения патологических состояний соединительной ткани
RU2185388C2 (ru) * 2000-06-28 2002-07-20 Карапутадзе Темури Мусаевич Способ получения поли-1,4-этиленпиперазина и его производных
NZ601248A (en) * 2008-04-14 2014-06-27 Halozyme Inc Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions
RU2417097C2 (ru) * 2008-04-24 2011-04-27 Валерия Леонидовна Багирова Фармацевтическая композиция, содержащая гиалуронидазу и липосомы для наружного применения
RU2428991C9 (ru) 2010-06-24 2011-12-27 ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НПО Петровакс Фарм" Сополимеры гетероцепных алифатических поли-n-оксидов, вакцинирующие и лекарственные средства на их основе
RU2556378C2 (ru) * 2013-07-11 2015-07-10 ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НПО Петровакс Фарм" Конъюгат гликопротеина, обладающего активностью эритропоэтина, с производными n-оксида поли-1,4-этиленпиперазина (варианты), фармацевтическая композиция и способ получения конъюгата

Also Published As

Publication number Publication date
CN108697732A (zh) 2018-10-23
EP3384917A1 (en) 2018-10-10
US11364283B2 (en) 2022-06-21
MD4637C1 (ro) 2020-01-31
WO2017095264A1 (ru) 2017-06-08
CA3007389C (en) 2021-01-12
UA121425C2 (uk) 2020-05-25
HUE056845T2 (hu) 2022-03-28
EA201650048A1 (ru) 2017-06-30
MD20180043A2 (ro) 2018-11-30
RS62659B1 (sr) 2021-12-31
CN108697732B (zh) 2021-02-26
RU2616528C1 (ru) 2017-04-17
SI3384917T1 (sl) 2022-01-31
KR20200131355A (ko) 2020-11-23
GEP20207131B (en) 2020-07-10
JP2019501217A (ja) 2019-01-17
CA3007389A1 (en) 2017-06-08
MD4637B1 (ro) 2019-06-30
TR201807851T1 (tr) 2018-06-21
KR20180090339A (ko) 2018-08-10
KR102358980B1 (ko) 2022-02-08
EP3384917B1 (en) 2021-09-15
LT3384917T (lt) 2021-11-25
EA030139B1 (ru) 2018-06-29
US20180344815A1 (en) 2018-12-06
AR108562A1 (es) 2018-09-05
EP3384917A4 (en) 2019-09-04
JP6683827B2 (ja) 2020-04-22

Similar Documents

Publication Publication Date Title
IL290959A (en) Preparations containing antibody-drug conjugates and methods for their production
HK1232140A1 (zh) 微類器官以及製造和使用它們的方法
IL250744A0 (en) A method for preparing flavociclib and its pharmaceutical preparations
EP3145919A4 (en) Methods for producing beraprost and its derivatives
GB201519128D0 (en) Solid forms and methods of preparing the same
PL3194328T3 (pl) Żelowa poduszka formowana i sposób jej wytwarzania
HK1259290A1 (zh) 用聚乙烯哌嗪衍生物製備透明質酸酶綴合物的方法以及所得綴合物的應用
SG11201708502PA (en) Graphene-based membrane and method of producing the same
EP3283493A4 (en) Texaphyrin-phospholipid conjugates and methods of preparing same
GB201907083D0 (en) 99mtc-labelled isonitrile-containing glucose derivative and preparation method and use
PT3334826T (pt) Papoila de elevado teor de tebaína e métodos de produção da mesma
SG11201509451WA (en) Microorganism producing o-acetyl homoserine and the method of producing o-acetyl homoserine using the same
SG11201803485UA (en) Method for producing silazane-siloxane copolymers and the use of such copolymers
GB201415317D0 (en) Process for producing fluorocytosine and fluorocytosine derivatives
HK1245337A1 (zh) 活化的甲酰甘氨酸生成酶及其生成和使用方法
EP3233124A4 (en) Nanowire-coated microdevice and method of making and using the same
PL3135110T3 (pl) Pochodne 1,7-diarylo-1,6-heptadieno-3,5-dionu, sposób ich wytwarzania i ich zastosowanie
SI3672770T1 (sl) Postopek za proizvodnjo ukrivljenih pohištvenih delov
SG11201610266RA (en) Choux pastry and method for producing the same
EP3448375C0 (en) BENZOYLGLYCINE DERIVATIVES AND METHODS OF PRODUCING AND USING SUCH DERIVATIVES
PL3124026T3 (pl) Preparat iniekcyjny i sposób jego wytwarzania
PL3323366T3 (pl) Kriosonda i sposób jej wytwarzania
IL246831B (en) A method for the production of 1-indanols and 1-indanamines
EP3263572A4 (en) Method for producing kakeromycin and derivatives thereof
SG11201701354VA (en) Oligosaccharide preparation and method for producing the same